Colesevelam HCl
Sponsors
Daiichi Sankyo, KineMed, Carine Beysen, University of Colorado, Denver, HealthPartners Institute
Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2HealthyHypercholesterolemiaHyperlipidemiaHyperlipidemiasImpaired Glucose Tolerance
Phase 2
Phase 3
Phase 4
Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol
CompletedNCT00145574
Start: 2005-11-30End: 2007-12-31Updated: 2010-04-15
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale
CompletedNCT01122108
Start: 2010-04-30End: 2010-06-30Updated: 2010-10-07
Unknown Phase
Effects of Colesevelam HCl On Bile Acid Kinetics
CompletedNCT00476710
Start: 2007-05-31End: 2009-04-30Updated: 2015-04-01
Mechanisms of Glucose Lowering Effect of Colesevelam HCl
CompletedNCT00596427
Start: 2007-11-30End: 2009-04-30Updated: 2012-10-12
Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus
CompletedNCT00938405
Start: 2009-07-31End: 2009-12-31Updated: 2014-05-20
The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
CompletedNCT01092663
Start: 2010-03-31End: 2011-07-31Updated: 2013-01-17